Znanstveni rad - Pregledni rad
Recombinant Interferon-β in the Treatment of Polycythemia Vera and Related Neoplasms: Rationales and Perspectives
Cancers, 14 (2022), 22; 5495. https://doi.org/10.3390/cancers14225495

Hasselbalch, Hans; Skov, Vibe; Kjær, Lasse; Larsen, Morten Kranker; Knudsen, Trine A.; Lucijanić, Marko; Kušec, Rajko

Citirajte ovaj rad

Hasselbalch, H., Skov, V., Kjær, L., Larsen, M. K., Knudsen, T. A., Lucijanić, M. i Kušec, R. (2022). Recombinant Interferon-β in the Treatment of Polycythemia Vera and Related Neoplasms: Rationales and Perspectives. Cancers, 14. (22). doi: 10.3390/cancers14225495

Hasselbalch, Hans, et al. "Recombinant Interferon-β in the Treatment of Polycythemia Vera and Related Neoplasms: Rationales and Perspectives." Cancers, vol. 14, br. 22, 2022. https://doi.org/10.3390/cancers14225495

Hasselbalch, Hans, Vibe Skov, Lasse Kjær, Morten Kranker Larsen, Trine A. Knudsen, Marko Lucijanić i Rajko Kušec. "Recombinant Interferon-β in the Treatment of Polycythemia Vera and Related Neoplasms: Rationales and Perspectives." Cancers 14, br. 22 (2022). https://doi.org/10.3390/cancers14225495

Hasselbalch, H., et al. (2022) 'Recombinant Interferon-β in the Treatment of Polycythemia Vera and Related Neoplasms: Rationales and Perspectives', Cancers, 14(22). doi: 10.3390/cancers14225495

Hasselbalch H, Skov V, Kjær L, Larsen MK, Knudsen TA, Lucijanić M, i sur.. Recombinant Interferon-β in the Treatment of Polycythemia Vera and Related Neoplasms: Rationales and Perspectives. Cancers [Internet]. 09.11.2022. [pristupljeno 29.11.2024.];14(22). doi: 10.3390/cancers14225495

H. Hasselbalch, et al., "Recombinant Interferon-β in the Treatment of Polycythemia Vera and Related Neoplasms: Rationales and Perspectives", Cancers, vol. 14, br. 22, Studeni 2022. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:105:878867. [Citirano: 29.11.2024.]

Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.